| 000 | 01503 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515000137.0 | ||
| 264 | 0 | _c20051213 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/01.HYP.0000179583.64413.c1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarnock, David G | |
| 245 | 0 | 0 |
_aImprovement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cSep 2005 |
||
| 300 |
_a469-70 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 |
_aAmiloride _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEpithelial Sodium Channels |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSodium Channel Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aSodium Channels _xdrug effects |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBell, P Darwin | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 46 _gno. 3 _gp. 469-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.HYP.0000179583.64413.c1 _zAvailable from publisher's website |
| 999 |
_c15752971 _d15752971 |
||